Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia.

Giuseppe Todeschini(University of Pisa), G. Perona(University of Verona), Vittorio Meneghini(University of Verona), Cristina Tecchio(University of Verona), Vincenzo Cassibba, Giovanni Pizzolo(Fondazione IRCCS Istituto Nazionale dei Tumori), Achille Ambrosetti(International Extranodal Lymphoma Study Group), Dino Veneri, Roberta Zanotti(University of Verona), Gianpaolo Nadali(Azienda Ospedaliera Universitaria Integrata Verona)
PubMed
March 1, 1994
Cited by 35

Related Papers

ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
|Blood|2003|490
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells
|Blood|2004|159
<i>Pneumocystis carinii</i> pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres
|British Journal of Haematology|2002|149